Objective: Lime has a long history as a contraceptive and vaginal hygiene douche, and ongoing use in Africa is documented. We report on the first safety study on diluted lime juice to assess its potential as a candidate microbicide.
INTRODUCTION W
OMEN CONSTITUTE THE MAJORITY of the 13,000 new HIV infections occurring every day, and the need for a woman-controlled method of deterring HIV infection has been recognized for a long time. Although the usefulness of microbicides has been appreciated for 20 years, the research remains underfunded and largely ignored by pharmaceutical companies. Several artificial compounds are in phase III efficacy trials, but it may take several years until the first products reach the market with a sustainable distribution and user education network. [1] [2] [3] The impact on the trajectory of the epidemic depends not only on the theoretical efficacy of a preventive method but also on its use effectiveness and on how fast it can reach large-scale use.
Today, women are still lacking microbicides and are often not empowered to use available HIV prevention methods. In desperation, many turn to anything that suggests protection, especially in places where the use of vaginal potions has a long-standing tradition. Throughout history and across cultures, women have tried to control their fertility and genital health with a variety of substances. Today, 30%-50% of African women use intravaginal practices with substances such as soap, toothpaste, vinegar, herbal compositions, lemons, commercial preparations, and antiseptics. 4, 5 Seventy-two percent of women interviewed in Kenya, 99% of interviewees in Indonesia, and 98% of interviewed pregnant women in Cote d'Ivoire report using douches. [6] [7] [8] Intravaginal herbs and powders for dry sex are perceived to enhance sexual pleasure in parts of Africa and some Latin American countries. 4, 7, [9] [10] [11] These vaginal practices are often associated with adverse health outcomes, such as elevated risk for infection and negative impact on the vaginal flora. 5, 6, 8 Despite decades of attempts to communicate these risks to the public, the frequent use of vaginal practices continues. A recent study by Grimley et al. 12 estimates the regular use of vaginal douche product among U.S. women years of age) to be 11.8%; it is much higher among African American women, at 27.7%.
The use of lime or lemon juice for genital hygiene also has a long history. Casanova 13 described the use of half a lemon as a cervical cap. Douching with lemon juice was recommended as a spermicide contraceptive by Margaret Sanger in the 1950s and remains in use today. [14] [15] [16] [17] Nigeria has the largest documented use of limes. Following anecdotal reports, 18 Perlman's investigation 9 estimates that in Northern Nigeria about one quarter of commercial sex workers (CSW) use limes or lemons vaginally, and almost half of them use concentrations of Ն50%. Most CSWs douche one or more times a day, believing that the practice can protect them against sexually transmitted infections (STIs) and pregnancy. Another study from Nigeria reported that 81% of CSWs and 21% of family planning clients use lemons or limes, either undiluted or diluted, before or after intercourse. Twelve percent of the CSWs had used lemons and limes intravaginally for over 10 years. 19 In theory, using lime or lemon for HIV prevention makes sense. The estrogenized vagina of women of childbearing age is normally acidic because of the normal lactobacilli flora, which keeps the vaginal pH at Յ4.5. This low pH is a good defense against many pathogens, including HIV. However, about one quarter of all women worldwide suffer from bacterial vaginosis (BV) and the absence of acidifying lactobacilli. 20, 21 The administration of lime or lemon juice could help maintain a healthy low vaginal pH or even inactivate HIV directly.
Acidic substances destroy HIV. Vinegar has been used to inactivate STI in monkey vaginas. 22 Some first-generation microbicides are acid buffers (BufferGel and Acidform), maintaining the vagina's natural acidity and buffering the alkaline semen. 23, 24 Initial in vitro experiments testing a 20% concentration of lime and lemon showed sperm immobilized within 1 minute 25 and 80% of HIV inactivated in 2 minutes. 26 When cynomolgus monkeys were exposed to undiluted lime juice for 28 days, the histology of their genital tracts did not differ from that of the control group. 27 Neurath et al. 28 demonstrated that a 4-fold dilution of fruit juices like blueberry, cranberry, grape, lime, and especially pomegranate showed some HIV inhibitory activity. They suggest that not only the acidity but also other properties must play a role for HIV inhibition in fruit juices. 28 The study reported here is the first safety trial of lime juice, designed for the following reasons: (1) if lime juice is harmful to the vagina, this knowledge needs to be communicated to the current users, and (2) if lime juice does not damage the vagina, further research on efficacy is justified.
MATERIALS AND METHODS

Participants
Twenty-six participants of reproductive age were initially enrolled, and 25 completed the study. Volunteers reporting an STI or pregnancy in the 3 months prior to the trial were excluded at the screening interview. Participants agreed to refrain from sexual activity and the use of vaginal products throughout the study period.
Outcome measures
The primary outcome was the assessment of acquired vaginal irritation as measured by (1) colposcopy, (2) biochemical markers in vaginal lavage and, (3) self-reported clinical symptoms.
Randomization
Because stored lime juice facilitates the growth of Candida albicans, 29 the women prepared their concentrations each day from fresh limes, which required an open-label trial. Participants were randomly allocated their concentrations but, once assigned, were unblinded, although the two experienced physicians conducting the gynecological examinations and laboratory tests were blinded. Because of the limited toxicity data for long-term exposure to higher concentrations of lime juice at the commencement of the study 26, 30 (R. Shattock, personal communication, 2005) , the maximum level of exposure was set at 20% lime juice. To receive as much safety information as possible with a budget sufficient for the enrollment of only 25 subjects, a 3:1:1 randomization was used. The majority of the participants (15 women) used the maximum lime concentration of 20% (2 parts lime and 8 parts bottled water). A smaller small group of 5 women using a 10% lime concentration was enrolled to assess possible toxicity at a lower concentration. A small group of 5 women using bottled water (0% lime concentration) was included as a control group.
Study procedures
The trial design followed the current recommendations of the International Working Group on Microbicides 31, 32 and CONRAD/ WHO. 33 The trial length was 15 days, as is standard in other microbicide safety trials. 23, 24, 34, 35 Lime juice leaks out of the vagina too quickly to ensure a standardized and prolonged exposure time. To achieve a constant and immediate contact of lime juice with the vaginal mucosa, overnight application of a soaked tampon (house brand of Walgreen's Pharmacy Chain, Deerfield, IL, with plastic applicator, normal absorbency) was selected instead of other possible application modes, such as douching.
The baseline examination (day 1) was scheduled after menstruation to ensure a 2-week study period without menstrual bleeding. The examination included inspection of the external and internal genitalia. Urine analysis, a pregnancy test, and an HIV serology test were performed. A Thin-Prep Liquid Pap test analyzed at the West Coast Pathology Laboratories (Hercules, CA) provided results for Papanicolaou cytology, Chlamydia trachomatis, Neisseria gonorrhoeae, herpes simplex virus (HSV), and human papillomavirus (HPV) typing. Wet mount microscopy was used to detect Trichomonas vaginalis and C. albicans. A gram stain provided information on lactobacilli and curved rods to assess bacterial vaginosis, using the Nugent score. Microscopy (400 ϫ) quantified lactobacilli as 0, few (5-10 visible per high power field), moderate (1-50), or many (Ͼ50). A lavage with phosphate-buffered saline (PBS) was performed to retrieve a sample for inflammatory biomarkers from the posterior fornix. After a literature review, [36] [37] [38] eight biomarkers were selected: interleukin-1␣ (IL-1␣), IL-1␤, IL-6, IL-8, IL-10, tumor necrosis factor-␣ (TNF-␣) RANTES, and macrophage inflammatory protein-1␤ (MIP-1␤). The colposcopy followed a standardized protocol. 32, 33 The volunteers received detailed instructions, fresh limes, a syringe for preparing the exact dilution, pH paper, bottled water, tampons, and a standardized daily log. They started the treatment the evening after the baseline examination. The tampon was left in the lime mix for 1 minute to ensure that it reached the saturation point of about 8.5 mL. The participants performed daily pH measurements in the upper vaginal tract (inserting the pH paper on the extended index finger as far up as possible) immediately before tampon insertion and immediately after tampon removal. They evaluated the occurrence of 11 different genital symptoms every day using a scale of none, mild, moderate, and severe. Participants were urged to report any deviation from the study protocol (such as missing days and sexual activity). Unknown to the participants, the pH strips provided and those remaining were counted before and after the trial to estimate the level of protocol adherence.
The end point examination took place on day 15. Again, a naked eye examination, a urine analysis, a wet mount, a gram stain, vaginal lavage, and colposcopy were performed. Women with detected candidiasis or bacterial vaginosis at baseline or end point examination were treated after completion of the trial. With the exception of 1 woman, each participant was examined by the same provider at baseline and end point. Participants were students from a big U.S. university. All examinations were conducted at the University Health Services. The research was approved by the Institutional Review Board of UC Berkeley (04- and conducted between March and June 2005. No financial or other compensation besides the provision of a free annual gynecological examination and STI testing was offered to the participants.
Statistical analysis
All data were analyzed in SPSS 12.0 (Chicago, IL), Stata 8 (Statacorp, College Station, TX), and Excel (Microsoft, Redmond, WA). The small sample size often precluded the use of extensive statistics. Mostly simple frequencies and means were calculated. To compare the results for the inflammatory biomarkers, we used the Wilcoxon signed ranks test for small sample sizes (2-tailed). To compare the adverse events between the groups, the Fisher's exact test was used.
RESULTS
Twenty-five women completed the study. One additional participant enrolled in the 20% group and withdrew from the study for personal reasons on day 6, not showing any signs of genital irritation at her exit examination. She was not included in the data analysis.
Demographics
All participants had a college education. The women in all groups were of similar age, and ethnicity and had similar patterns of sexual activity and contraceptive use.
Missing days
Participants reported the days of missed treatment in their daily log; no significant difference was found between the groups. Participants in the control group (0%) reported an average of 12.4 of 14 possible treatment days. No days were missed in the 10% group, and among the women using 20% lime juice, an average of 13.1 treatment days was reached (Table 1) .
Genital infections
At baseline, no participant tested positive for urinary tract infection, trichomoniasis, chlamydiasis, gonorrhea, or candidiasis. Two women showed clue cells and had no lactobacilli in their gram stain (Nugent score Ն7: bacterial vaginosis). The Papanicolaou smears of 2 women were of undetermined significance (atypical squamous cells of undetermined significance [ASCUS]), and both tested positive for HPV.
At end point, again no participant tested positive for urinary tract infection, trichomoniasis, chlamydiasis, or gonorrhea. Two women (10% and 20% group) showed a newly developed yeast infection with clinical symptoms and positive laboratory test; both were treated. The 2 women (10% and 20% group) with clue cells at baseline did not have them at end point, when a third woman (20% group) showed clue cells for the first time (Table 2) .
Adverse events
More than 70% of participants in all groups experienced at least one mild or moderate side effect; about 60% reported side effects on two or more occasions (Table 3) . Ninety percent of all adverse events were mild and transient sensations HEMMERLING ET AL. 1044 of dryness, itching, or burning at tampon insertion. A third of the lime users reported itching at least once. Nine of the 20 lime users experienced burning at least once, 4 of them grading it as moderate on one or more occasions. In the 20% group, 5 participants described symptoms as moderate on a total of 20 different occasions, all of them resolving without intervention. No participant in any group reported severe symptoms. Comparing the frequencies of each adverse event per group between the placebo group (0% lime juice) and the 20% lime group, only burning (p ϭ 0.005) and dryness ( p ϭ 0.042) occurred significantly more often in the 20% group.
pH
The mean exposure time was approximately 8 hours per night in all groups. The pH for the lime preparations was 2.0-2.5 for both the 10% and 20% groups. The pH difference between insertion and removal of the tampon as measured daily by the participants was not significant in any group. Similarly, the pH determined by the medical practitioners at baseline and end point examination showed no significant change. At baseline, 80% of all participants had a vaginal pH of Յ4.5 (mean pH 4.36). At end point, 90% of the participants using lime had a pH of Յ4.5 (mean pH: 20% group 4.4, 10% group 4.2, placebo group 4.4).
Lactobacilli
Lime exposure had no significant impact on the quantity of vaginal lactobacilli when compared with the control group. At baseline, 9 of 25 participants had the highest detectable quantity, "many," on the gram stain (out of many, moderate, few, none). At end point, 2 women had decreased lactobacilli quantities, and 4 women had increased colonization.
Colposcopy results
At baseline, all colposcopies were normal, with epithelium and blood vessels intact in all cases. Some women showed notable but nonpathological characteristics, such as a small cervical polyp (1 women), Nabothian cysts (5 women), or prominent superficial blood vessels on the cervical face (3 women). At end point colposcopy (Table 4) , two minor findings were noted in the 20% group: 1 woman had a new nonfriable cervical erythema, and 1 of the women with a yeast infection had vulvar erythema. No one had with signs of severe irritation, such as ulcerations or vascular lesions. The 2 women with ASCUS Pap smears had normal colposcopies.
Inflammatory biomarkers
The baseline results varied greatly among participants. Established ranges for normal findings in vaginal lavages are not currently available. Consequently, changes were compared only between baseline and end point results for participants within each group (Table 5) . For TNF-␣ and IL-10, the amounts were too low to be detectable. For most of the other markers, individual values varied considerably and showed no significant relation between baseline and end point results for the participants within each group. Within the 20% group, a significant increase for IL-8 and MIP-1␤ was noted. The control group (0% lime) showed a significant increase for RANTES. The 3 participants who developed yeast and BV infections showed substantial increases for the majority of the selected cytokines. 
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DISCUSSION
An acceptable safety profile for lime juice diluted to 20% or lower was demonstrated in this safety study. The colposcopy did not detect any case of epithelial disruption. More than two thirds of all participants reported at least one mild or moderate side effect. Dryness of the vagina was the most common adverse event. However, as 80% of our control group using a water-soaked tampon also reported adverse events, it is possible that some of the effects were due to tampon use itself. Other phase I safety studies with BufferGel and PRO 2000 showed similar frequencies of adverse events and colposcopic findings. 23, 24, 34 Again, symptoms occured very frequently even in the absence of gel use, 39 which may reflect the intense participant monitoring in safety trials.
The 2 cases of yeast infection were not unexpected, as other studies using acidic vaginal preparations have shown similar increases in C. albicans. 29 In a safety trial with BufferGel, yeast infections among 98 participants rose from 0% at enrollment to 19% after 2 weeks. 24 Two of our participants with BV at baseline had normal findings at the end point examination. The BufferGel safety trial also showed a sharp decline in BV from 30% at enrollment to 7% after 2 weeks. 24 Several studies describe the relationship of acidity and decreased BV or increased yeast infections. [40] [41] [42] [43] [44] As seen in trials using acid buffers, our study with lime showed no impact on lactobacilli colonization. 45 The significant decrease in pH LIME JUICE AS CANDIDATE MICROBICIDE 1047 seen in some studies with acid buffers or acidic substances 23 was not seen in our cohort. Fichorova et al. 36, 37 found that the cytokines IL-1␣ and IL-1␤ as well as IL-6 and IL-8 are especially well suited to predict mucosal toxicity in microbicide safety trials. The absence of a significant increase in IL-1␣, IL-1␤, and IL-6 among lime users in our study confirmed our nonpathological colposcopic findings. The fact that IL-8 and MIP-1␤ significantly increased in the 20% group despite the lack of overt clinical findings could be interpreted as the potential superiority of cytokines to detect mild forms of vaginal irritation when compared with such traditional techniques as colposcopy. However, as the control group (water) also saw a significant increase in RANTES, our data do not show a clear and consistent association of increased biomarkers and lime exposure. The participants experiencing episodes of yeast infection or BV had increases for some of the selected cytokines. Overall, the increase in the grade and type of adverse events coupled with elevated IL-8 in the 20% group might suggest that a toxicity threshold is being approached.
This study was the first completed phase I trial investigating the safety of lime juice, a practice followed by thousands of women with no data on safety or efficacy. Using an existing research infrastructure in the United States made it possible to implement the trial quickly and economically with a very modest budget. This trial is one of the few to date that assessed cytokines to determine the safety of a potential microbicide candidate. The data can contribute to establish normal and pathological ranges for inflammatory biomarkers in vaginal secretions.
The main limitation of our study is the very small sample size (n ϭ 25). It is noteworthy, however, that phase I safety trials in microbicide research were often done with small sample sizes subdivided into different groups and from different sites, sometimes without a control group, sometimes including sexually active as well as nonactive participants. 23, 24, 34 The less favorable open-label design was unavoidable in this study, as the lime juice mix had to be freshly prepared and applied by the participants themselves. Another study investigating the safety of lime juice chose a similar unblinded design for the same reasons. 46 Additionally, selecting a study population of healthy young women (as is common in phase I trials) may have led to results possibly differing from those in a group of more susceptible women with preexisting vaginal infections and ulcerations. Equally, the response found in a study population of predominantly Caucasian women cannot necessarily be generalized to women of other ethnic backgrounds. Because of limited in vitro research available at the time of the trial commencement in March 2005, only comparatively low concentrations of up to 20% lime juice were tested. The majority of current lime users in Nigeria are applying stronger concentrations. 9 The interpretation of the cytokine data was limited because of the relative novelty of the field.
Initial reports on limes and lemons have drawn in a number of researchers interested in the topic. Preliminary clinical data from 2006 by Mauck et al. 46 evaluating colposcopy results suggest that a lime concentration of 50% or 100% applied vaginally twice a day (tampon insertion over long intervals or douching) can cause deep epithelial disruption. Other new preclinical studies have raised questions about the potential efficacy of low concentrations of lime juice. In cell-based assays, lemon and lime juice were reported to have a therapeutic index (TI) of 1-3 (i.e., no margin between antiviral effect and cellular/tissue toxicity), being similar to nonoxynol-9. 47 Other microbicide candidates, such as PRO2000 and UC781, have demonstrated TI values of Ͼ333 and Ͼ1600, respectively. 48 Another recent in vitro study showed that the presence of alkaline semen (instead of sperm only) significantly reduced the anti-HIV effect of lime juice. A 50% lime concentration required an exposure of 30 minutes to completely inhibit HIV in semen. When reducing the concentration to 25% lime, the protection was incomplete, as only one of the two independent experiments inhibited HIV sufficiently. 49 To date, it is not known how well these in vitro assays predict clinical outcomes for safety and efficacy. Current tissue models tend to overestimate toxicity as well as the microbicide dose required to inhibit HIV. Although there is no consensus regarding the minimal level of antiviral activity that should be mediated by potential HIV microbicides, 50 current evidence suggests that the 20% concentration of lime juice used in our study is safe but may not be high enough to be effective.
Even if future studies could identify a dose high enough to be effective but low enough to be safe, this dose range is likely to be extremely narrow and not practical for settings where women will be un-able to prepare solutions requiring precise measurements. Women currently using lime juice often douche after intercourse, washing out a significant proportion of the potentially infectious semen, but postcoital application of lime juice may be too late to prevent HIV transmission. Douching with a low concentration of lime juice solely before intercourse would almost certainly be incapable of buffering the full amount of semen. Given its low viscosity, insufficient amounts of lime juice will remain intravaginally throughout the duration of intercourse. Douching itself is often associated with adverse health outcomes, such as elevated risk for infection and increased impact on the vaginal flora, 5, 6, 8, 51 although other studies challenge a causal relationship of vaginal practices and HIV transmission. 52 Our safety study required women to abstain from sex. In real life situations, vaginal abrasions inflicted during intercourse are common, especially in the presence of STIs. The astringent properties of lime and lemon could cause dryness, leading to microtears because of diminished lubrication. 53, 54 and disrupted epithelium is more susceptible to HIV transmission.
CONCLUSIONS
Our study shows that low concentrations of lime juice (10% and 20%) are relatively safe for vaginal use. However, new preclinical findings indicate that these concentrations may be too low to effectively buffer semen and destroy HIV. Concentrations likely to be effective (50% and higher) have been shown to be toxic in tissue models and new preliminary clinical data. Women should, therefore, be discouraged from commencing or continuing the use of lime juice and seek other methods to prevent HIV transmission.
